Yüklüyor......
Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines
Background: Low effectiveness of chemotherapy in ovarian cancer results from development of drug resistance during treatment. Topotecan (TOP) is a chemotherapeutic drug used in second-line chemotherapy of this cancer. Unfortunately, during treatment cancer can develop diverse cellular and tissue spe...
Kaydedildi:
| Yayımlandı: | J Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ivyspring International Publisher
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277650/ https://ncbi.nlm.nih.gov/pubmed/30519347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27342 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|